SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-05-000019
Filing Date
2005-11-01
Accepted
2005-11-01 16:38:01
Documents
2
Period of Report
2005-10-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMEX HEARING AND DELIST amexhear.htm 8-K 23036
2 AMEX HEARING DELIST pressreleaseamexhear.htm EX-99.1 17670
  Complete submission text file 0000812796-05-000019.txt   42481
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 051170197
SIC: 2834 Pharmaceutical Preparations